Recombinant MRS2 is produced in Escherichia coli with an N-terminal His tag, enabling purification via affinity chromatography .
The mature protein spans residues 57–455 (UniProt ID: Q6C8H7) and is stored as a lyophilized powder in Tris/PBS-based buffer with 6% trehalose (pH 8.0) .
MRS2 belongs to the CorA-MRS2-ALR superfamily, characterized by a conserved GMN motif (Gly-Met-Asn) critical for Mg²⁺ transport .
Cryo-EM structures reveal a homo-pentameric assembly with two transmembrane helices (TM1/TM2) and a large cytosolic domain .
Mediates Mg²⁺ influx into the mitochondrial matrix, essential for ATP synthesis, ribozyme function, and metabolic pathways .
Complements yeast mrs2 mutants, restoring Mg²⁺-dependent growth and mitochondrial RNA splicing .
Mg²⁺ Dependency: Growth retardation in Arabidopsis MRS2-7 mutants under low Mg²⁺ (50 μM) .
Transport Efficiency: High Mg²⁺ uptake rates observed in yeast mitochondrial assays .
Pathological Relevance: Knockdown disrupts mitochondrial metabolism and promotes cell death .
ELISA and Binding Studies: Commercial recombinant MRS2 is utilized for antibody development and protein interaction assays .
Structural Biology: Cryo-EM structures (e.g., 2.8 Å resolution) elucidate Mg²⁺ translocation mechanisms .
Y. lipolytica is a preferred host for recombinant protein expression due to its high secretory capacity and genetic tractability .
MRS2 serves as a model for studying Mg²⁺ transport dysregulation in metabolic diseases .
Therapeutic Targeting: Modulating MRS2 activity could address mitochondrial Mg²⁺ deficiency linked to neurodegenerative disorders .
Engineered Strains: Integration of MRS2 into multi-gene Y. lipolytica platforms for synthetic biology applications .
- Commercial product specifications (Creative Biomart)
- Functional complementation in Arabidopsis (PMC2814501)
- Cryo-EM structures and gating mechanisms (Nature, 2023; Nature Structural & Molecular Biology, 2024)
- Regulatory role of the N-terminal domain (Life Science Alliance, 2023)
KEGG: yli:YALI0D19514g
STRING: 4952.XP_503035.1
MRS2 (Mitochondrial RNA splicing protein 2) functions as a magnesium transporter located in the inner mitochondrial membrane. The protein contains two transmembrane domains that constitute a pore for Mg²⁺ entry into the mitochondrial matrix. In Yarrowia lipolytica, MRS2 is encoded by the MRS2 gene (YALI0D19514g) and consists of a 455 amino acid sequence .
The protein structure includes several key features:
N-terminal domain (NTD) that resides within the mitochondrial matrix
Two transmembrane domains forming the magnesium transport channel
Conserved GMN motif essential for magnesium selectivity
Unlike the pentameric assembly seen in bacterial ortholog CorA, research suggests that human MRS2 NTD self-associates into a homodimer, and this structural arrangement may be conserved in Yarrowia lipolytica . The protein plays a crucial role in maintaining mitochondrial magnesium homeostasis, which is essential for various mitochondrial functions including ATP synthesis and enzyme activities.
The regulatory mechanisms of MRS2 show both similarities and differences between yeast and human systems:
| Regulatory Aspect | Human MRS2 | Yarrowia lipolytica MRS2 |
|---|---|---|
| Oligomeric state | Homodimeric NTD | Likely homodimeric (based on homology) |
| Mg²⁺ feedback inhibition | NTD mediates autoregulation | Presumed similar mechanism |
| Response to divalent cations | Mg²⁺ and Ca²⁺ suppress oligomerization | Not specifically documented |
| Transcriptional regulation | Multiple transcription factors | Part of the 87 TF-encoding genes deregulated during recombinant protein expression |
Human MRS2 displays a negative feedback regulation mechanism mediated by its NTD. When matrix Mg²⁺ concentrations rise, binding to the NTD induces conformational changes that inhibit further transport . Although not explicitly characterized in Yarrowia lipolytica, functional conservation suggests similar regulatory mechanisms exist.
The transcriptional regulation of MRS2 in Yarrowia lipolytica likely involves multiple transcription factors, as studies have shown that recombinant protein expression significantly alters the expression of 87 transcription factor genes in this organism .
When conducting experiments with recombinant Yarrowia lipolytica MRS2, several essential controls should be implemented:
Expression verification controls:
Western blot analysis using antibodies against the protein or tag (e.g., His-tag)
Mass spectrometry validation of purified protein identity
RNA expression analysis (RT-qPCR) to confirm transcription
Functional controls:
Wild-type MRS2 expression in parallel with mutant constructs
MRS2 knockout strains as negative controls
Complementation assays to verify functional rescue
Purification quality controls:
SDS-PAGE with Coomassie staining to assess purity
Size exclusion chromatography to verify oligomeric state
Thermal stability assays to ensure proper folding
Species-specific considerations:
Codon optimization for Yarrowia lipolytica expression
Proper subcellular targeting verification using mitochondrial markers
Assessment of post-translational modifications using proteomics
The choice of expression system is critical, as functional studies of mitochondrial membrane proteins require proper insertion into lipid bilayers. For optimal expression of functional MRS2, inclusion of phospholipids (particularly phosphatidylcholine) during purification is recommended, as they have been shown to restore activity in other mitochondrial membrane proteins from Yarrowia lipolytica .
Investigating Mg²⁺ binding to the MRS2 NTD requires sophisticated biophysical and biochemical techniques:
Isothermal Titration Calorimetry (ITC):
Fluorescence-based approaches:
Intrinsic tryptophan fluorescence to detect conformational changes
Fluorescent Mg²⁺ indicators to monitor transport activity
FRET-based assays using labeled MRS2 constructs to detect oligomerization changes
Structural biology techniques:
X-ray crystallography of the NTD with and without Mg²⁺
Cryo-EM analysis of full-length MRS2 in different conformational states
NMR spectroscopy to map Mg²⁺ binding sites and induced structural changes
Computational approaches:
Molecular dynamics simulations to predict Mg²⁺ binding sites
Homology modeling based on bacterial CorA structures
Molecular docking to identify potential binding pockets
Functional transport assays:
Reconstitution in liposomes with fluorescent Mg²⁺ indicators
Mitochondrial Mg²⁺ uptake assays using Mag-Fura-2 or similar indicators
Patch-clamp electrophysiology of reconstituted channels
Research has demonstrated that mutations in key residues of the human MRS2 NTD not only decrease Mg²⁺ binding affinity but also abolish Mg²⁺-induced changes in secondary, tertiary, and quaternary structures . Similar experimental approaches can be applied to study the Yarrowia lipolytica MRS2.
Site-directed mutagenesis is a powerful approach for investigating structure-function relationships in MRS2:
Divalent cation binding sites:
Mutations in acidic residues (Asp, Glu) likely involved in Mg²⁺ coordination
Mutations in the NTD that affect autoregulation (based on homology to human MRS2)
Alterations to the conserved GMN motif critical for ion selectivity
Oligomerization interfaces:
Mutations at predicted dimer interfaces to disrupt self-association
Introduction of cysteine residues for disulfide cross-linking to trap specific conformations
Charge-reversal mutations to destabilize quaternary structure
Transmembrane domains:
Scanning mutagenesis of the pore-lining residues
Hydrophobicity alterations to affect membrane insertion
Introduction of bulky residues to probe channel dimensions
Functional assessment:
Mitochondrial Mg²⁺ uptake measurements in wild-type and knockout cells expressing mutant constructs
Growth complementation assays in MRS2-deficient yeast strains
Electrophysiological measurements of channel activity
Structural assessment:
Circular dichroism to detect secondary structure changes
Limited proteolysis to probe conformational stability
Native gel electrophoresis to assess oligomeric state changes
Expression and localization verification:
Fluorescence microscopy with tagged constructs to confirm mitochondrial targeting
Western blotting of mitochondrial fractions to verify expression levels
Protease protection assays to confirm proper membrane topology
A particularly valuable approach would be to generate mutations analogous to those identified in human MRS2 that lead to gain-of-function phenotypes, as these could provide insight into the evolutionary conservation of regulatory mechanisms. Research has shown that disruption of NTD Mg²⁺ binding in human MRS2 potentiates mitochondrial Mg²⁺ uptake, identifying a negative feedback autoregulation mechanism .
Optimizing recombinant MRS2 expression in Yarrowia lipolytica requires consideration of multiple factors:
Promoter selection:
Strong constitutive promoters (e.g., TEF, GPD) for high-level expression
Inducible promoters (e.g., POX2) for controlled expression
Hybrid promoters with enhanced activity for maximal yields
Codon optimization:
Adaptation to Yarrowia lipolytica codon usage bias
Avoidance of rare codons, especially in critical domains
Balanced GC content to enhance mRNA stability
Secretion and localization signals:
Native MRS2 mitochondrial targeting sequence
Optimized signal sequences for proper subcellular localization
Addition of epitope or affinity tags for detection and purification
Media composition:
Carbon source selection (glucose, glycerol, oleic acid)
Nitrogen source optimization (peptone, yeast extract, ammonium sulfate)
Supplementation with magnesium and other cofactors
Growth parameters:
Temperature (typically 28-30°C for Yarrowia lipolytica)
pH optimization (typically pH 5.5-6.5)
Dissolved oxygen levels for proper mitochondrial function
Induction strategies:
Timing of induction relative to growth phase
Inducer concentration for controllable expression
Fed-batch strategies to maintain optimal nutrient levels
Transcriptional regulation engineering:
Recent research on Yarrowia lipolytica has revealed that manipulation of transcription factors (TFs) can significantly impact recombinant protein production. Of the 140 TFs identified in Yarrowia lipolytica, 87 are significantly deregulated during recombinant protein expression . Co-overexpression of specific TFs with the target protein can enhance yields, while knockout of repressive TFs may also improve expression.
A systematic approach involving the testing of different expression constructs, culture conditions, and host strain modifications is recommended to identify optimal conditions for each specific recombinant protein.
Purification of functional MRS2 from Yarrowia lipolytica requires specialized approaches for membrane proteins:
Gentle cell lysis:
Enzymatic digestion of cell wall (using lyticase or zymolyase)
Mechanical disruption via glass bead homogenization
Nitrogen cavitation for gentle membrane isolation
Mitochondrial isolation:
Differential centrifugation to separate mitochondria
Density gradient centrifugation for highly pure mitochondrial fractions
Mitoplast preparation by selective outer membrane disruption
Membrane protein solubilization:
Detergent screening (mild detergents like DDM, LMNG, or digitonin)
Lipid:protein ratio optimization during solubilization
Addition of stabilizing agents (glycerol, specific lipids)
Tag-based strategies:
Hexa-histidine tagging for IMAC purification
Strep-tag II or FLAG tag for highly specific binding
Tandem affinity tags for increased purity
Chromatographic methods:
Ion exchange chromatography as secondary purification
Size exclusion chromatography for oligomeric state assessment
Hydrophobic interaction chromatography for membrane protein separation
Lipid supplementation:
Buffer optimization:
Inclusion of Mg²⁺ at physiological concentrations
pH optimization based on mitochondrial matrix pH
Ionic strength adjustment for oligomeric stability
Storage considerations:
The purification strategy should be validated by assessing protein functionality through magnesium transport assays, structural integrity analysis, and binding studies.
Quantitative assessment of MRS2-mediated magnesium transport requires multiple complementary approaches:
Liposome-based assays:
Reconstitution of purified MRS2 into liposomes
Loading of liposomes with fluorescent Mg²⁺ indicators (Mag-Fura-2, Magnesium Green)
Measurement of Mg²⁺ influx kinetics using stopped-flow spectrofluorometry
Determination of transport parameters (Vmax, Km) for different mutants
Electrophysiological methods:
Planar lipid bilayer recordings of reconstituted MRS2
Patch-clamp analysis of giant liposomes containing MRS2
Measurement of channel conductance, open probability, and ion selectivity
Mitochondrial Mg²⁺ measurements:
Expression of MRS2 variants in MRS2-knockout cells
Loading of cells with mitochondrially-targeted Mg²⁺ indicators
Real-time confocal microscopy to monitor Mg²⁺ uptake kinetics
Flow cytometry for population-level analysis
Isolated mitochondria studies:
Preparation of mitochondria from cells expressing MRS2 variants
Measurement of Mg²⁺ uptake using membrane-impermeable indicators
Analysis of respiratory chain activity as a functional readout
Assessment of mitochondrial membrane potential correlation with Mg²⁺ transport
Mg²⁺ binding assays:
Isothermal titration calorimetry to determine binding affinity changes
Fluorescence-based binding assays using intrinsic or extrinsic fluorophores
Equilibrium dialysis with radioactive ²⁸Mg²⁺
Structural impact assessment:
Circular dichroism to detect secondary structure changes upon Mg²⁺ binding
Limited proteolysis to identify conformational changes
Native gel electrophoresis to assess oligomeric state alterations
A comprehensive approach would involve:
Expressing wild-type and mutant MRS2 in Yarrowia lipolytica
Purifying the proteins and reconstituting them into liposomes
Performing parallel transport assays using multiple methodologies
Correlating transport activity with structural changes and binding parameters
Research has shown that disruption of Mg²⁺ binding to the NTD of human MRS2 potentiates mitochondrial Mg²⁺ uptake in both wild-type and MRS2 knockout cells, suggesting this domain plays a critical role in autoregulation . Similar experimental approaches could be applied to Yarrowia lipolytica MRS2.
Investigating MRS2 interactions with other mitochondrial proteins requires specialized approaches for membrane protein complexes:
Co-immunoprecipitation (Co-IP):
Antibody-based pulldown of tagged MRS2
Western blot analysis of co-precipitated proteins
Mass spectrometry identification of novel interaction partners
Proximity labeling techniques:
BioID or TurboID fusion to MRS2 for in vivo biotinylation of proximal proteins
APEX2 fusion for proximity-dependent protein labeling
Mass spectrometry analysis of biotinylated proteins
Crosslinking mass spectrometry:
Chemical crosslinking of intact mitochondria
Digestion and enrichment of crosslinked peptides
Mass spectrometry identification of interaction interfaces
Förster resonance energy transfer (FRET):
Expression of fluorescently tagged MRS2 and candidate partners
Live-cell imaging of interaction dynamics
Spectroscopic analysis of FRET efficiency
Bioluminescence resonance energy transfer (BRET):
Luciferase fusion for donor emission
Reduced background compared to fluorescence approaches
Suitable for real-time monitoring in intact cells
Split reporter systems:
BiFC (Bimolecular Fluorescence Complementation)
Split luciferase complementation
Protein-fragment complementation assays (PCA)
Genetic interaction analysis:
Synthetic lethality/sickness screening
Suppressor screening to identify functional partners
Double knockout/knockdown phenotypic analysis
Metabolic profiling:
Analysis of changes in mitochondrial metabolism
Measurement of respiration rates in single and double mutants
Assessment of mitochondrial membrane potential
Proteomics approaches:
Quantitative proteomics of wild-type vs. MRS2 mutant mitochondria
Analysis of protein complex assembly by blue native PAGE
Correlation of MRS2 levels with other mitochondrial proteins
Yarrowia lipolytica offers unique advantages for studying these interactions due to its obligate aerobic metabolism and well-developed genetic tools. The species contains complexes I-IV of the respiratory chain, making it an excellent model for studying mitochondrial protein interactions . Genetic manipulation techniques, including deletion strain generation and complementation with plasmids carrying the deleted gene, provide powerful tools for functional interaction studies.
Poor expression or mislocalization of recombinant MRS2 in Yarrowia lipolytica can be addressed through systematic troubleshooting:
Vector and promoter adjustments:
Testing different promoter strengths (TEF, GPD, POX)
Optimizing the Kozak sequence for improved translation initiation
Using intron-containing constructs to enhance mRNA processing
Codon optimization approaches:
Full codon optimization for Yarrowia lipolytica
Targeted optimization of rare codons in problematic regions
Elimination of potential cryptic splice sites
Protein stabilization strategies:
Co-expression with molecular chaperones (HSP70, HSP90)
Inclusion of fusion partners to enhance solubility
Expression as truncated domains for structural studies
Targeting sequence optimization:
Using the native Yarrowia lipolytica MRS2 mitochondrial targeting sequence
Testing different N-terminal targeting sequences from well-characterized mitochondrial proteins
Creating chimeric targeting sequences with enhanced import efficiency
Import machinery considerations:
Co-expression of components of the mitochondrial protein import machinery
Optimization of growth conditions to maintain mitochondrial membrane potential
Modulation of cellular energetics to support mitochondrial protein import
Visualization strategies:
C-terminal fluorescent protein fusions to monitor localization
Split GFP approach for minimally invasive tagging
Immunofluorescence microscopy with antibodies against tags or the protein itself
Strain engineering approaches:
Recent research has identified that transcription factors play a significant role in recombinant protein expression in Yarrowia lipolytica. Of the 140 TFs in this yeast, 87 were significantly deregulated during recombinant protein expression . Strategic overexpression or knockout of specific TFs could enhance MRS2 expression. Additionally, engineering strains with enhanced mitochondrial content or altered mitochondrial dynamics may improve expression of mitochondrial membrane proteins.
A systematic approach investigating multiple variables simultaneously (e.g., using design of experiments methodology) can efficiently identify optimal conditions for recombinant MRS2 expression and localization.
Distinguishing direct from indirect effects in MRS2 functional studies requires careful experimental design:
Rescue experiments:
Complementation of MRS2 knockout with wild-type or mutant variants
Use of orthologous MRS2 proteins from other species
Expression of engineered MRS2 variants with altered regulation
Temporal control systems:
Inducible expression systems to monitor acute effects
Degron-tagged MRS2 for rapid protein depletion
Optogenetic control of MRS2 activity or expression
Domain-specific mutations:
Separation-of-function mutations that affect specific aspects of MRS2 function
Structure-guided mutations targeting different functional domains
Systematic alanine scanning to map functional surfaces
In vitro reconstitution:
Purified component systems to test direct effects
Stepwise addition of components to identify minimal required factors
Comparison of activities in defined versus complex systems
Direct binding assays:
Surface plasmon resonance to measure direct interactions
Microscale thermophoresis for solution-based interaction studies
Isothermal titration calorimetry for thermodynamic characterization
Proximity labeling with spatial resolution:
Targeted enzymatic tagging (BioID, APEX) fused to specific MRS2 domains
Split enzymatic systems requiring direct protein interaction
Quantitative analysis of labeling efficiency as measure of proximity
Multi-parameter phenotyping:
Parallel measurement of multiple mitochondrial parameters
Time-resolved analysis to establish cause-effect relationships
Dosage-dependent studies to establish thresholds
Metabolic flux analysis:
13C metabolic flux analysis to track metabolic changes
Correlation analysis between Mg²⁺ levels and metabolic pathways
Mathematical modeling to predict direct versus indirect effects
Comparative studies across conditions:
Analysis under different nutrient conditions
Comparison of effects in fermentative versus respiratory growth
Temperature-dependent phenotypes to distinguish enzymatic from structural roles
Research has shown that MRS2 NTD mutations in human cells potentiate mitochondrial Mg²⁺ uptake, demonstrating direct regulation . Similar experimental frameworks applied to Yarrowia lipolytica MRS2 would help establish evolutionary conservation of these direct regulatory mechanisms.
When comparing wild-type and mutant MRS2 function in transport assays, several essential controls must be included:
Protein level verification:
Western blotting of whole cell lysates, mitochondrial fractions, and purified protein
Quantitative assessment of expression levels with appropriate loading controls
Flow cytometry of tagged constructs for population distribution analysis
Subcellular localization confirmation:
Immunofluorescence microscopy with mitochondrial markers
Subcellular fractionation with Western blot analysis
Protease protection assays to confirm membrane topology
Membrane insertion verification:
Carbonate extraction to distinguish peripheral from integral membrane proteins
Detergent solubility profiles to assess membrane integration
Limited proteolysis to probe accessibility of domains
Positive and negative transport controls:
Parallel assays with known functional and non-functional MRS2 variants
Inclusion of specific MRS2 inhibitors when available
Ionophore controls for maximum transport capability
Ion selectivity controls:
Parallel assays with other divalent cations (Ca²⁺, Mn²⁺, Co²⁺)
Competition experiments between Mg²⁺ and other ions
Assessment of transport in presence of chelators with different affinities
Energetic state controls:
Measurements with and without respiratory substrates
Membrane potential dissipation controls (CCCP, valinomycin)
ATP depletion to assess energy dependence
Technical replicates:
Multiple measurements from the same biological preparation
Statistical analysis of measurement variance
Instrument calibration with standard solutions
Biological replicates:
Independent preparations from separate cultures
Multiple clones of the same construct
Experiments performed on different days
Dose-response relationships:
Varying external Mg²⁺ concentrations to determine Km and Vmax
Protein expression level titration to assess stoichiometric effects
Inhibitor concentration gradients for IC50 determination
Normalization approaches:
Normalization to protein expression levels
Correction for mitochondrial content differences
Standardization based on maximum transport capacity
Kinetic parameter extraction:
Initial rate measurements versus equilibrium assessments
Curve fitting to appropriate transport models
Statistical comparison of derived parameters
Multi-parameter analysis:
Correlation between transport activity and structural parameters
Integration of transport data with other functional readouts
Principal component analysis for complex phenotypic data
Research has shown that disruption of Mg²⁺ binding to the NTD of human MRS2 potentiates mitochondrial Mg²⁺ uptake, highlighting the importance of careful controls when interpreting functional changes . Similar experimental rigor applied to Yarrowia lipolytica MRS2 studies would ensure reliable and reproducible results.
Several cutting-edge technologies hold promise for advancing MRS2 research:
Cryo-electron microscopy advancements:
Single-particle analysis of MRS2 in different conformational states
Cryo-electron tomography of MRS2 in native mitochondrial membranes
Time-resolved structures capturing transport dynamics
Integrative structural biology:
Combination of X-ray crystallography, cryo-EM, and NMR data
Molecular dynamics simulations constrained by experimental data
Cross-linking mass spectrometry to validate predicted interfaces
In situ structural determination:
Cryo-focused ion beam milling of intact mitochondria
Correlative light and electron microscopy of tagged MRS2
Visual proteomics approaches for contextual structural information
Genetically encoded Mg²⁺ sensors:
Development of mitochondrially targeted Mg²⁺ indicators
Ratiometric sensors for quantitative measurements
FRET-based sensors for local Mg²⁺ concentration monitoring
Super-resolution microscopy:
STED or STORM imaging of MRS2 distribution within mitochondria
Single-molecule tracking to monitor dynamics
Multi-color imaging to correlate with other mitochondrial proteins
Label-free imaging techniques:
Stimulated Raman scattering microscopy for metabolic imaging
Nano-infrared spectroscopy for chemical composition analysis
Mass spectrometry imaging for spatial metabolomics
CRISPR-based approaches:
Base editing for precise point mutations
CRISPRi/CRISPRa for tunable expression control
CRISPR screening for genetic interactors
Synthetic biology strategies:
De novo design of MRS2 variants with altered properties
Engineering orthogonal Mg²⁺ transport systems
Creation of synthetic genetic circuits for controlled expression
Multi-omics integration:
Combined proteomics, metabolomics, and transcriptomics analysis
Systems biology modeling of Mg²⁺ homeostasis networks
Machine learning approaches to predict functional outcomes
These emerging technologies would significantly enhance our understanding of MRS2 structure, function, and regulation in Yarrowia lipolytica, potentially revealing novel aspects of mitochondrial magnesium transport mechanisms and their evolutionary conservation across species.
Research on MRS2 in Yarrowia lipolytica has significant potential to advance multiple areas of mitochondrial biology:
Comparative studies across species:
Identification of conserved versus divergent features in MRS2 structure and function
Adaptation of magnesium transport to different cellular contexts
Evolution of regulatory mechanisms for mitochondrial ion homeostasis
Ancestral reconstruction approaches:
Inference of primordial MRS2 properties
Experimental testing of evolutionary hypotheses
Understanding selective pressures on mitochondrial magnesium transport
Horizontal gene transfer exploration:
Assessment of bacterial influences on eukaryotic magnesium transport
Comparative analysis of prokaryotic CorA and eukaryotic MRS2
Reconstruction of evolutionary trajectories for mitochondrial ion channels
Magnesium as a metabolic regulator:
Role of Mg²⁺ in controlling mitochondrial enzyme activities
Coordination between Mg²⁺ homeostasis and energy metabolism
Integration of ion transport with respiratory chain function
Stress response pathways:
MRS2 function under different metabolic and environmental stresses
Adaptation of magnesium transport to changing cellular demands
Role in maintaining mitochondrial integrity during stress
Signaling networks:
Interplay between mitochondrial and cytosolic magnesium pools
Cross-talk between magnesium and calcium signaling pathways
Integration of mitochondrial ion transport with nuclear gene expression
Yarrowia lipolytica as a production platform:
Engineering magnesium homeostasis for optimal protein production
Enhancement of mitochondrial function for metabolic engineering
Development of Yarrowia lipolytica as a model for mitochondrial disease studies
Mitochondrial medicine implications:
Identification of therapeutic targets for mitochondrial disorders
Development of small-molecule modulators of magnesium transport
Creation of disease models for testing interventions
Synthetic biology opportunities:
Design of artificial magnesium-responsive genetic circuits
Engineering of novel ion selectivity in transport proteins
Development of biosensors for mitochondrial magnesium
Yarrowia lipolytica offers unique advantages as a model system due to its obligate aerobic metabolism and well-developed genetic tools . As an oleaginous yeast with industrial importance, insights gained from MRS2 research could have implications beyond basic science, potentially informing applications in biotechnology and medicine.